Efficacy and safety of a first line combined therapeutic approach for young CLL patients with advanced or progresive disease stratified according to the biologic features: first analysis of the GIMEMA Multicenter Study LLC0405

MAURO F. R;MOLICA S;CORTELEZZI A;PICIOCCHI A;LAURENTI L;BRUGIATELLI M;RIZZI, Rita;MIRABELLI R;ZAJA F;STAGNO F;CIOLLI S;FORCONI F;CALLEA V;ANGRILLI F;MUSOLINO C;BUCCISANO F;MASSAIA M;DEL POETA G;SANTANGELO S;MARINELLI M;NANNI M;DE PROPRIIS M. S;DEL GIUDICE I;VIGNETTI M;MORABITO F;TORELLI G;STORTI S;LEVIS A;CARELLA A. M;DI RAIMONDO F;LEONE G;LAURIA F;SPECCHIA G;CUNEO A;MELONI G;GUARINI A;FOÀ R.

2010-01-01